Subsequent Events - Additional Information (Detail) - USD ($)		1 Months Ended
	Jul. 14, 2025	Jul. 31, 2025	Jul. 08, 2025	Jun. 30, 2025	May 12, 2025	Dec. 31, 2024
Subsequent Event [Line Items]
Common stock par or stated value per share				$ 0.0001	$ 0.0001	$ 0.0001
Common stock shares issued				1,483,738		696,969
Common stock shares outstanding				1,483,738		696,969
Subsequent Event [Member]
Subsequent Event [Line Items]
Proceeds from warrant exercise		$ 1,000,000
Subsequent Event [Member] | Biolabs Merger Agreement [Member]
Subsequent Event [Line Items]
Termination fee			$ 0
Subsequent Event [Member] | THPlasma Merger Agreement [Member]
Subsequent Event [Line Items]
Common stock par or stated value per share	$ 0.001
Preferred stock par or stated value per share	$ 0.001
Common stock shares issued	19,666,667
Common stock shares outstanding	19,666,667
License purchase aggregate consideration payable in cash	$ 5,000,000
Subsequent Event [Member] | THPlasma Merger Agreement [Member] | Minimum [Member]
Subsequent Event [Line Items]
License purchase aggregate consideration payable in cash	$ 5,000,000
Subsequent Event [Member] | Common Stock [Member] | THPlasma Merger Agreement [Member]
Subsequent Event [Line Items]
Common stock, shares issued during the period	6,666,667
Class of warrants or rights number of securities covered by warrants or rights		298,000
Proceeds from warrant exercise		$ 1,000,000